Target intelligence / Profile preview

Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5)

Target
GALNTL5
Molecular classification
Enzyme (Glycosyltransferase-like family, polypeptide N-acetylgalactosaminyltransferase family), Other (inactive/putative enzyme)
01

Overview

Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5) is a member of the polypeptide N-acetylgalactosamine-transferase family, possessing conserved catalytic domains found in glycosyltransferases but lacking a functional lectin domain and verified enzymatic activity in vitro. This protein is almost exclusively expressed in the testis and is essential for spermatid maturation and normal sperm motility, likely participating in processes such as protein loading into acrosomes and assembly of the ubiquitin-proteasome system at the sperm neck region. Genetic mutations leading to loss or dysfunction of GALNTL5 are associated with male infertility, especially due to asthenozoospermia (immotile sperm syndrome). Despite being an “enzyme-like” protein, direct transferase activity for GALNTL5 has not been demonstrated in vitro, leading it to be considered an inactive or atypical member of its enzyme family. There are currently no clinically established drug interactions, mechanisms of action, or established use as a biomarker or therapeutic target.

Other names
GALNT15GalNAc-T5LPolypeptide GalNAc transferase 15Polypeptide GalNAc transferase-like 5UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15Protein-UDP acetylgalactosaminyltransferase 15Pp-GaNTase 15GalNAc-T15GALNACT19Testis tissue sperm-binding protein Li 61n
02

Biological functions

Spermiogenesis and spermatid developmentProtein loading into acrosomesAccumulation and localization of ubiquitin-proteasome systems in sperm
03

Disease associations

Male infertility (specifically, asthenozoospermia)Optic nerve hypoplasia (rare, limited evidence)

Beyond the preview

Go deeper on Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call